Paragon nabs $15M filovirus vax contract from DoD


The U.S. Department of Defense has awarded Paragon Bioservices, a contract manufacturing organization, a $15 million contract to develop a mammalian process to manufacture vaccines for filoviruses, which are considered potential bioweapons.  Paragon also has been working on vaccines that would guard against the Ebola and related Marburg viruses. Story

Filed Under
, filoviruses, Paragon Bioservices